Arthneeti
Latest: Privi Speciality Chemicals Ltd Q2 FY27 results →All Q3 FY26 results →
PS

Privi Speciality Chemicals Ltd

Q3 FY26Chemicals & Petrochemicals

Privi Speciality Chemicals Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Price₹3,480
Market cap₹14.3K Cr
P/E40.7
Updated23 Aug 2026
Read4 min read

The short version

FY '28 will be a transition year for growth, with a material scale-up expected in FY '29. FY '28 is expected to be a transition year in terms of growth, with some stabilization issues as new product facilities come on stream (Q1 FY '28).

From Privi Speciality Chemicals Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • FY '28 will be a transition year for growth, with a material scale-up expected in FY '29. (Page 18)
  • Volume growth for the coming financial year is expected to be around 7%, with potential to be higher (possibly between 11%-15%) due to new projects starting. (Page 6 & 11)
  • Capacity expansion will increase from 48,000 metric tons to 54,000 metric tons by March-April 2027, maintaining around 90% utilization. (Page 12)
  • Further expansion includes an additional 18,000 metric tons capacity focused on multi-speciality and speciality products beyond existing products. (Page 12)
  • A 20% CAGR growth target is maintained, with a roadmap to achieve INR5,000 crore revenue by FY '29. (Pages 6, 11)

2 more points from Privi Speciality Chemicals Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Privi Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The company has planned a total capex of INR 1,200 crores over 3 years (FY26 to FY28), split as:
  • Phase 1: INR 300 crores
  • Phase 2: INR 600 crores
  • Phase 3: INR 300 crores
  • This capex aims to support growth beyond 54,000 metric tons capacity and achieve INR 5,000 crores revenue by FY28-29.
  • Capex includes new product facilities expected to come on stream by Q1 FY28, with potential stabilization issues for a quarter.
  • Additional facility and automation required for a new corn cob product plant targeting 20,000-ton scale by ’27-’28.
  • Joint venture (Prigiv) with Givaudan plans an investment of INR 50 crores for capacity expansion, funded by equity (Privi 51%, Givaudan 49%).

2 more points from Privi Speciality Chemicals Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries Ltd
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Privi Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Rohit Nagraj asked about revenue visibility and contracts for new products;
  • Narayan Iyer mentioned that contracts are typically 70% on contract and 30% spot market.
  • Overall, business outlook suggests a positive demand environment with 7%-15% volume growth expected in the next financial year, supported by capacity expansions.
  • The company maintains a strong pipeline aligned with their INR 1,200 crore capex and 3-phase expansion plan to reach INR 5,000 crore revenues by FY 28-'29.

Privi Speciality Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹760 Cr, net profit ₹118 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Privi Speciality Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Neochem Bio Solutions Ltd (Q3 FY26)

    Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and

  • Thirumalai Chemicals Ltd (Q3 FY26)

    Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran

  • IVP Ltd (Q3 FY26)

    Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector

  • Gujarat Alkalies (Q3 FY26)

    3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Privi Speciality Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Privi Speciality Chemicals Ltd Q3 FY26 results?

FY '28 will be a transition year for growth, with a material scale-up expected in FY '29. FY '28 is expected to be a transition year in terms of growth, with some stabilization issues as new product facilities come on stream (Q1 FY '28).

What is Privi Speciality Chemicals Ltd share price analysis?

Privi Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 40.7 with a market cap of ₹14,250 Cr. Investors should review the full earnings analysis for detailed insights.

Is Privi Speciality Chemicals Ltd planning capital expenditure?

The company has planned a total capex of INR 1,200 crores over 3 years (FY26 to FY28), split as: - Phase 1: INR 300 crores - Phase 2: INR 600 crores - Phase 3: INR 300 crores - This capex aims to support growth beyond 54,000 metric tons capacity and achieve INR 5,000 crores revenue by FY28-29.

Keep Privi Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.